Longitudinal analysis of low-molecular weight fluorophores in type 1 diabetes mellitus

Journal of Medical Investigation

Volumn 55, Issue 1-2, 2008, Pages 29-36

  Januszewski, Andrzej S ^a   Thomas, Merlin C ^b   Karschimkus, Connie S ^a   Chung, Jasmine S ^a   Rowley, Kevin G ^a   Nelson, Craig L ^a   O'Neal, David N ^a   Dragicevic, George ^a   Harper, Colin A ^a   Best, James D ^a   Jenkins, Alicia J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Advanced glycation end products; Low molecular weight fluorophores; Renal function; Type 1 diabetes

Indexed keywords

ADVANCED GLYCATION END PRODUCT; C REACTIVE PROTEIN; GLUCOSE; LOW MOLECULAR WEIGHT FLUOROPHORE;

ADULT; ARTICLE; BIOCHEMISTRY; CARBOHYDRATE ANALYSIS; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC PATIENT; DIET RESTRICTION; DISEASE DURATION; DRUG TARGETING; FEMALE; FLUORESCENCE SPECTROSCOPY; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; LONGITUDINAL STUDY; MALE; OXIDATION; PREDICTION; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; SYSTEMIC VASCULAR RESISTANCE;

ADULT; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOLECULAR WEIGHT; OXIDATIVE STRESS; SPECTROMETRY, FLUORESCENCE; STAINING AND LABELING;

EID: 43149101007     PISSN: 13431420     EISSN: None     Source Type: Journal    
DOI: 10.2152/jmi.55.29     Document Type: Article

References (26)

1. Thorpe SR, Baynes JW : Maillard reaction products in tissue proteins : new products and new perspectives. Amino Acids 25 : 275-281, 2003
2. Jenkins AJ, Rowley KG, Lyons TJ, Best JD, Hill MA, Klein RL : Lipoproteins and diabetic microvascular complications. Curr Pharm Des 10 : 3395-3418, 2004
3. Jenkins AJ, Best JD, Klein RL, Lyons TJ : 'Lipoproteins, glycoxidation and diabetic angiopathy'. Diabetes Metab Res Rev 20 : 349-368, 2004
4. Bakris GL, Bank AJ, Kass DA, Neutel JM, Preston RA, Oparil S : Advanced glycation end-product cross-link breakers : a novel approach to cardiovascular pathologies related to the aging process. Am J Hypertens 17 : 23S-30S, 2004
5. Davis BJ, Forbes JM, Thomas MC, Jerums G, Burns WC, Kawachi H, Allen TJ, Cooper ME : Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat. Diabetologia 47 : 89-97, 2004
6. Lapolla A, Fedele D, Seraglia R, Traldi P : The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes : An update. Mass Spectrom Rev, 2006
7. Sharp PS, Rainbow S, Mukherjee S : Serum levels of low molecular weight advanced glycation end products in diabetic subjects. Diabet Med 20 : 575-579, 2003
8. Thomas MC, Tsalamandris C, MacIsaac R, Medley T, Kingwell B, Cooper ME, Jerums G : Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes. Kidney Int 66 : 1167-1172, 2004
9. Galler A, Muller G, Schinzel R, Kratzsch J, Kiess W, Munch G : Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes, as determined by fluorescence spectroscopy and nepsilon-(carboxymethyl) lysine ELISA Diabetes Care 26 : 2609-2615, 2003
10. Makita Z, Radoff S, Rayfield EJ, Yang Z, Skolnik E, Delaney V, Friedman EA, Cerami A, Vlassara H : Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 325 : 836-842, 1991
11. Stein G, Franke S, Mahiout A, Schneider S, Sperschneider H, Borst S, Vienken J : Influence of dialysis modalities on serum AGE levels in end-stage renal disease patients. Nephrol Dial Transplant 16 : 999-1008, 2001
12. Januszewski AS, Thomas MC, Chung SJ, Karschimkus CS, Rowley KG, Nelson C, O'Neal D, Wang Z, Best JD, Jenkins AJ : Plasma low-molecular weight fluorescence in type 1 diabetes mellitus. Ann NY Acad Sci 1043 : 655-661, 2005
13. Wilson AM, O'Neal D, Nelson CL, Prior DL, Best JD, Jenkins AJ : Comparison of arterial assessments in low and high vascular disease risk groups. Am J Hypertens 17 : 285-291, 2004
14. Cockcroft DW, Gault MH : Prediction of creatinine clearance from serum creatinine. Nephron 16 : 31-41, 1976
15. Gault MH, Longerich LL, Harnett JD, Wesolowski C : Predicting glomerular function from adjusted serum creatinine. Nephron 62 : 249-256, 1992
16. Vlassara H : Advanced glycation in health and disease : role of the modern environment. Ann NY Acad Sci 1043 : 452-460, 2005
17. Januszewski AS, Alderson NL, Metz TO, Thorpe SR, Baynes JW : Role of lipids in chemical modification of proteins and development of complications in diabetes. Biochem Soc Trans 31 : 1413-1416, 2003
18. Wrobel K, Garay-Sevilla ME, Nava LE, Malacara JM : Novel analytical approach to monitoring advanced glycosylation end products in human serum with on-line spectrophotometric and spectrofluorometric detection in a flow system. Clin Chem 43 : 1563-1569, 1997
19. Gerdemann A, Lemke HD, Nothdurft A, Heidland A, Munch G, Bahner U, Schinzel R : Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis. Clin Nephrol 54 : 276-283, 2000
20. Makita Z, Bucala R, Rayfield EJ, Friedman EA, Kaufman AM, Korbet SM, Barth RH, Winston JA Fuh H, Manogue KR, Cerami A, Vlassara H : Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure. Lancet 343 : 1519-1522, 1994
21. Forbes JM, Cooper ME, Thallas V, Burns WC, Thomas MC, Brammar GC, Lee F, Grant SL, Burrell LA, Jerums G, Osicka TM : Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy. Diabetes 51 : 3274-3282, 2002
22. Tan KC, Chow WS, Ai VH, Metz C, Bucala R, Lam KS : Advanced glycation end products and endothelial dysfunction in type 2 diabetes. Diabetes Care 25 : 1055-1059, 2002
23. Kunt T, Forst T, Harzer O, Buchert G, Pfutzner A, Lobig M, Zschabitz A, Stofft E, Engelbach M, Beyer J : The influence of advanced glycation endproducts (AGE) on the expression of human endothelial adhesion molecules. Exp Clin Endocrinol Diabetes 106 : 183-188, 1998
24. Basta G, Schmidt AM, De Caterina R : Advanced glycation end products and vascular inflammation : implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 63 : 582-592, 2004
25. Baynes JW, Thorpe SR : Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med 28 : 1708-1716, 2000
26. Thornalley PJ, Battah S, Ahmed N, Karachalias N, Agalou S, Babaei-Jadidi R, Dawnay A : Quantitative screening of advanced glycation end-products in cellular and extracellular proteins by tandem mass spectrometry. Biochem J 375 : 581-592, 2003